33
Participants
Start Date
April 30, 2008
Primary Completion Date
February 28, 2013
Study Completion Date
January 31, 2015
Everolimus
Everolimus tablets, two-5 mg tablets a day
Fulvestrant
intramuscular, 500 mg in two divided doses- one on each side- on day 1, then 250mg on day 14, then 250 mg on day 28 and every 4 weeks +/- 3 days thereafter
University of Kentucky, Lexington
Collaborators (1)
Novartis
INDUSTRY
Mara Chambers
OTHER